Abstract:Abstract The decline in early life mortality since the 1950s has resulted in dramatic demographic shift towards aged population. Aging manifests as a decline in health, multiple organ dysfunction and increased vulnerability to diseases, which degrades quality of life. A verity of genetic and pharmacological interventions, mostly from non-vertebrate models, have been identified that can enhance lifespan. Whether these interventions extend healthspan, the disease free and functional period of life, has only sometimes been tested and is often a matter of debate. Human aging indices have been developed to assess elements of functional decline with aging (e.g. sarcopenia, cognitive function). However, corresponding comprehensive indices in mice are seldom applied to aging studies. To probe the relationship between healthspan and lifespan extension in mammals, we performed a series of longitudinal, clinically-relevant healthspan measurements. Metabolism and aging are tightly connected and specific perturbations of nutrient-sensing pathways can enhance longevity in laboratory animals. Here we show that alpha-ketoglutarate (delivered in the form of a Calcium salt, CaAKG), a key metabolite in tricarboxylic (TCA) cycle that is reported to extend lifespan in worms, can significantly extend lifespan and healthspan in mice. AKG is involved in various fundamental processes including collagen synthesis and epigenetic changes. Due to its broad roles in multiple biological processes, AKG has been a subject of interest for researchers in various fields. AKG also influences several age-related processes, including stem cell proliferation and osteoporosis. To determine its role in mammalian aging, we administered CaAKG in 18 months old mice and determined its effect on the onset of frailty and survival, discovering that the metabolite promotes longer, healthier life associated with a decrease in levels of inflammatory factors. Interestingly the reduction in frailty was more dramatic than the increase in lifespan, leading us to propose that CaAKG compresses morbidity.

JNK modifies neuronal metabolism to promote proteostasis and longevity

JNK Signaling in Drosophila Aging and Longevity

Dual treatment with kynurenine pathway inhibitors and NAD+ precursors synergistically extends life span in Drosophila

c-Jun N-terminal kinase signaling in aging

c-Jun N-terminal kinase signaling in cellular senescence

Downregulation of the tyrosine degradation pathway extends Drosophila lifespan

Neuronal MML-1/MXL-2 regulates systemic aging via glutamate transporter and cell nonautonomous autophagic and peroxidase activity

Gut-to-brain regulation of Drosophila aging through neuropeptide F, insulin and juvenile hormone

Translational Regulation of Non-autonomous Mitochondrial Stress Response Promotes Longevity

Senescent glia link mitochondrial dysfunction and lipid accumulation

The metabolite alpha-ketobutyrate extends lifespan by promoting peroxisomal function in C. elegans

Alpha-ketoglutarate extends Drosophila lifespan by inhibiting mTOR and activating AMPK

Epigenetic drift of H3K27me3 in aging links glycolysis to healthy longevity in Drosophila.

Genetic and metabolomic architecture of variation in diet restriction-mediated lifespan extension in Drosophila

Sirt6 regulates lifespan in Drosophila melanogaster

A new AMPK isoform mediates glucose-restriction induced longevity non-cell autonomously by promoting membrane fluidity

Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old age

Neuronal induction of BNIP3-mediated mitophagy slows systemic aging in Drosophila

Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice

Independent regulation of age associated fat accumulation and longevity

Lifespan regulation in α/β posterior neurons of the fly mushroom bodies by Rab27